Through the agreement, the renewable energy provided to Novartis will avoid the annual emission of around 96,400 tonnes of CO2 into the atmosphere. Enel Green Power is a global leader in the green energy sector with a managed capacity of around 46.4 GW across a generation mix that includes wind, solar, geothermal and hydropower, and is at the forefront of integrating innovative technologies into renewable power plants. Enel Green Power, within the Enel Group, is dedicated to the development and operation of renewables across the world, with a presence in Europe, the Americas, Asia, Africa and Oceania. “With this deal, Novartis is showcasing the possibilities that Pan-European VPPAs can offer to companies committed to fighting climate change in the continent.”
Novartis Chief Sustainability Officer at Novartis Montse Montaner said at his company environmental sustainability is aligned with Novartis’ purpose to reimagine medicine to improve and extend people’s lives. As Enel Green Power, we are very proud to be a strategic partner and the Green Enabler of part of a major milestone of their journey to be carbon neutral across operations and the company’s supply chain,” said Javier Vaquerizo, head of Global Commercial Office for Enel Green Power. This Pan-European VPPA will start in January 2022 and will help Novartis achieve its goals for 100% renewable electricity and carbon-neutrality across its European operations by 2025, Enel said in a press release on November 19. The energy through this VPPA will be generated by the 179.9 MW TICO Wind Farm, located in the Spanish province of Zaragoza, which will be operational in early 2022. “Novartis is a leading company in environmental and sustainability matters. “Energy efficiency and renewable energy solutions are the cornerstones of our strategy for reducing emissions. The company aims to drive sustainability through its operations, as well as those of its suppliers, and has set ambitious targets to minimise its impacts on climate, waste, and water, the press release read. ENEL
Italy’s Enel Green Power, the renewable energy subsidiary of Enel Group, and Swiss-based Novartis, the global medicines company, have signed a 10-year, 100% renewable Virtual Power Purchase Agreement (VPPA) for 78 MW of renewable power, Enel said. style=”font-size:40px; line-height: 1.3em; font-weight: 800; padding:7px;”>Enel Green Power, Novartis ink 10-year 100% renewable energy deal
By New Europe Online/KG
Enel solar energy production in North America. We are proud to be joined by Enel Green Power and other like-minded partners on our environmental sustainability journey,” he said. This agreement is part of the Novartis commitment to environmental sustainability by helping make the company both energy and climate-resilient. Novartis is committed to using resources efficiently and reducing greenhouse gas (GHG) emissions, which affect the climate.